Biomarker testing, a method for analyzing patients' biological markers to understand and diagnose diseases, is now officially covered by health insurers in Georgia. As detailed in a recent Senate Press column, Governor Kemp signed House Bill 85 into law back in May 2023. This significant legislative move, spearheaded by the Senate carrier of the bill, mandates insurance coverage for a technique that has notably aided cancer patients and is making headway in other medical areas, including Alzheimer's disease diagnosis.
Despite the fact the law was enacted over two years ago, many Georgians, including those who need these tests due to living with severe conditions, remain unaware of the existence of biomarker testing or their right to access it through their insurance plans. This lack of awareness permeates through a society that, albeit surrounded by advanced medical innovations, clings onto traditional forms of diagnosis and treatment. The Federal Drug Administration (FDA) has also approved a biomarker blood test for Alzheimer's, marking progress in the early detection of this debilitating condition.
It's crucial for healthcare professionals, community leaders, and caregivers to play their part in disseminating this information. As mentioned in the Senate Press piece, the intent is to not only inform but ensure that the public understands that biomarker testing is a fully covered benefit across Georgia health plans. The goal is to adopt medical advancements actively rather than passively acknowledging them.
In her role as Vice Chair of the Health and Human Services Committee, the state senator expressed pride in both her legislative and clinical work. In an effort to combine these spheres, she continues to push policies that favor increased healthcare access and better choices for Georgians, essentially advocating for a system that, from her perspective, would provide a more comprehensive care model.
